HMA/VEN: A New Pretransplant Paradigm for SOME People with AML
Transplantation and Cellular Therapy · 2026-05 · 32 (5) · 513-514
DOI: 10.1016/j.jtct.2026.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation and Cellular Therapy, 2026-05. Verfasst von Edward A Copelan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA. El…. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA. Electronic address: Edward.copelan@atriumhealth.org.
- Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
- Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA.
Zitieren
APA
Copelan, E. A., Gale, R. P., & Avalos, B. R. (2026). HMA/VEN: A New Pretransplant Paradigm for SOME People with AML. Transplantation and Cellular Therapy, 32(5), 513-514. https://doi.org/10.1016/j.jtct.2026.04.014
Vancouver
Copelan EA, Gale RP, Avalos BR. HMA/VEN: A New Pretransplant Paradigm for SOME People with AML. Transplantation and Cellular Therapy. 2026;32(5):513-514. doi:10.1016/j.jtct.2026.04.014
BibTeX
@article{Copelan2026,
author = {Copelan, Edward A and Gale, Robert P and Avalos, Belinda R},
title = {HMA/VEN: A New Pretransplant Paradigm for SOME People with AML},
journal = {Transplantation and Cellular Therapy},
year = {2026},
volume = {32},
number = {5},
pages = {513--514},
doi = {10.1016/j.jtct.2026.04.014}
}
EUVIMED